| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.0006 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.002 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |